LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ

Rutten, Guy; Tack, Cees; Pieber, Thomas; ÇÖMLEKÇİ, ABDURRAHMAN; Orsted, David; Baeres, Florian; Marso, Steven; Buse, John

doi:10.1186/s13098-016-0153-5

LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ

Rutten G. E. H. M., Tack C. J., Pieber T. R., ÇÖMLEKÇİ A., Orsted D. D., Baeres F. M. M., ...Daha Fazla

DIABETOLOGY & METABOLIC SYNDROME, cilt.8, 2016 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 8
Basım Tarihi: 2016
Doi Numarası: 10.1186/s13098-016-0153-5
Dergi Adı: DIABETOLOGY & METABOLIC SYNDROME
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Anahtar Kelimeler: Type 2 diabetes, External validity, Generalizability, Cardiovascular outcome trial, Heterogeneity
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Aims: To determine whether US and European participants in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial differ regarding risk factors for cardiovascular mortality and morbidity.